Genotoxicity of inhalational anesthetics and its relationship with the polymorphisms of GSTT1, GSTM1, and GSTP1 genes.


Journal

Environmental science and pollution research international
ISSN: 1614-7499
Titre abrégé: Environ Sci Pollut Res Int
Pays: Germany
ID NLM: 9441769

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 14 09 2018
accepted: 26 11 2018
pubmed: 7 12 2018
medline: 19 3 2019
entrez: 7 12 2018
Statut: ppublish

Résumé

Due to their wide applications, concern exists regarding possible genotoxic effects of inhalational anesthetics (IAs) among operating room personnel. This study was undertaken to examine genotoxic properties of co-exposure to nitrous oxide, sevoflurane, and isoflurane on induction of micronucleus (MN) and chromosomal aberrations (CAs) and to determine whether any associations exist between polymorphisms of GST genes and the level of genomic damage measured by MN and CAs assays. Sixty operating room personnel and 60 unexposed referent nurses were studied. The workers' exposure to the IAs was determined. DNA damage was evaluated by MN and CAs assays. Additionally, the GSTM1, GSTT1, and GSTP1 polymorphisms were detected. The mean concentrations of nitrous oxide, isoflurane, and sevoflurane were found to be 850.92 ± 919.78, 2.40 ± 0.86, and 0.18 ± 0.14 ppm, respectively. The frequency of MN and CAs in the exposed group was significantly higher than that of the non-exposed group. The frequency of MN was significantly higher in referent nurses with null GSTT1, compared to referent nurses with positive GSTT1. The frequency of MN was significantly higher in exposed individuals carrying the combined genotype of GSTT1 (-), GSTM1 (-), and GSTP1 AG as compared with subjects carrying a combination of GSTT1 (+), GSTM1 (+), and GSTP1 AA. Statistically significant associations were noted between exposure to the IAs, gender, and the combination of the three GSTs genotypes with MN frequency. These findings indicate that inhalation exposure to IAs induces genotoxic response and the polymorphisms of GSTs genes might modulate the effect of exposure to IAs on MN.

Identifiants

pubmed: 30519912
doi: 10.1007/s11356-018-3859-0
pii: 10.1007/s11356-018-3859-0
doi:

Substances chimiques

Anesthetics, Inhalation 0
Mutagens 0
glutathione S-transferase T1 EC 2.5.1.-
GSTP1 protein, human EC 2.5.1.18
Glutathione S-Transferase pi EC 2.5.1.18
Glutathione Transferase EC 2.5.1.18
glutathione S-transferase M1 EC 2.5.1.18

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3530-3541

Subventions

Organisme : Shiraz University of Medical Sciences
ID : 95-01-04-12366

Références

Occup Environ Med. 1999 Jul;56(7):433-7
pubmed: 10472312
Anesth Analg. 2001 Jan;92(1):118-22
pubmed: 11133612
Mutagenesis. 2001 Mar;16(2):139-43
pubmed: 11230556
Arh Hig Rada Toksikol. 2000 Dec;51(4):361-8
pubmed: 11276963
J Environ Pathol Toxicol Oncol. 2001;20(2):119-26
pubmed: 11394710
Blood. 2002 Jun 1;99(11):4216-8
pubmed: 12010828
Anesthesiology. 2002 Dec;97(6):1485-90
pubmed: 12459675
Mutagenesis. 2003 May;18(3):221-33
pubmed: 12714687
Environ Mol Mutagen. 2004;43(4):258-64
pubmed: 15141365
Cell Biochem Funct. 2005 Jul-Aug;23(4):267-72
pubmed: 15473001
Int Arch Occup Environ Health. 2005 Feb;78(1):60-4
pubmed: 15703947
East Afr Med J. 2004 Oct;81(10):538-9
pubmed: 15715133
Mutat Res. 2005 Mar 7;581(1-2):1-9
pubmed: 15725600
Pharmacogenet Genomics. 2006 Feb;16(2):87-99
pubmed: 16424821
Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):1038-42
pubmed: 16702390
Breast. 2006 Dec;15(6):754-61
pubmed: 16713266
Ann Occup Hyg. 2006 Aug;50(6):583-92
pubmed: 16799159
Mutat Res. 2006 Aug 30;600(1-2):58-66
pubmed: 16822529
Mutagenesis. 2006 Jul;21(4):249-54
pubmed: 16891636
Mutagenesis. 2006 Sep;21(5):335-42
pubmed: 16971395
Toxicology. 2007 Apr 11;232(3):235-47
pubmed: 17292523
Eur J Anaesthesiol. 2008 Mar;25(3):193-9
pubmed: 17892615
Br J Anaesth. 2007 Dec;99(6):812-8
pubmed: 17951609
Neurotoxicology. 2008 Jan;29(1):116-23
pubmed: 18022695
Int J Hyg Environ Health. 2009 Jan;212(1):11-7
pubmed: 18023252
Mutat Res. 2008 Feb 1;638(1-2):184-94
pubmed: 18035380
Mutat Res. 2008 Mar-Apr;658(3):215-33
pubmed: 18037339
Anaesthesia. 2008 Aug;63(8):861-4
pubmed: 18540930
Mutagenesis. 2008 Nov;23(6):423-37
pubmed: 18678752
Curr Drug Metab. 2009 Mar;10(3):236-46
pubmed: 19442086
Hear Res. 2009 Nov;257(1-2):8-15
pubmed: 19643173
Basic Clin Pharmacol Toxicol. 2010 Oct;107(4):818-24
pubmed: 20406204
Rev Bras Anestesiol. 2010 Mar-Apr;60(2):162-9, 93-7
pubmed: 20485961
Am J Ind Med. 2011 Feb;54(2):118-27
pubmed: 20607734
Ren Fail. 2010;32(10):1189-95
pubmed: 20954980
Mutagenesis. 2011 Jan;26(1):43-9
pubmed: 21164181
Interdiscip Toxicol. 2009 Sep;2(3):190-4
pubmed: 21217853
Expert Opin Drug Saf. 2011 Nov;10(6):891-9
pubmed: 21595613
Mutat Res. 2011 Oct 9;725(1-2):36-42
pubmed: 21736951
Mutat Res. 2011 Nov-Dec;728(3):88-97
pubmed: 21763453
Mutat Res. 2012 Mar 1;731(1-2):58-63
pubmed: 22085808
Environ Monit Assess. 2012 Nov;184(11):6483-90
pubmed: 22089627
Hum Exp Toxicol. 2013 Jun;32(6):563-70
pubmed: 23111880
Mutat Res. 2013 Jan 20;750(1-2):139-46
pubmed: 23159492
Scand J Work Environ Health. 2013 Nov;39(6):618-30
pubmed: 23525098
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
Environ Toxicol Pharmacol. 2014 Jan;37(1):267-74
pubmed: 24374387
Environ Toxicol Pharmacol. 2014 Jan;37(1):396-403
pubmed: 24440812
Acta Cir Bras. 2014 Apr;29(4):280-6
pubmed: 24760030
Drug Chem Toxicol. 2015;38(3):266-71
pubmed: 25156279
J Biochem Mol Toxicol. 2015 May;29(5):234-9
pubmed: 25646594
J Appl Genet. 2016 Aug;57(3):343-8
pubmed: 26685861
Indian J Anaesth. 2015 Nov;59(11):706-14
pubmed: 26755835
BMC Med Genet. 2016 May 14;17(1):40
pubmed: 27179909
Mutat Res. 2016 Sep - Oct;791-792:42-48
pubmed: 27639372
J Clin Anesth. 2016 Dec;35:326-331
pubmed: 27871551
Rev Bras Anestesiol. 2018 Jan - Feb;68(1):33-41
pubmed: 28655457
Arch Toxicol. 2018 Jun;92(6):1983-1990
pubmed: 29204680
Int Arch Occup Environ Health. 2018 Apr;91(3):349-359
pubmed: 29242980
J Anesth. 2018 Apr;32(2):269-282
pubmed: 29404778
J Occup Environ Med. 2018 Aug;60(8):e377-e382
pubmed: 29851738
Hum Exp Toxicol. 2018 Jan 1;:960327118783532
pubmed: 29932008
Cytobios. 1985;43(172-173):233-46
pubmed: 4075848
Mutat Res. 1995 Jan;341(3):169-84
pubmed: 7529358
Environ Mol Mutagen. 1996;27(2):93-7
pubmed: 8603671
Int Arch Occup Environ Health. 1996;68(3):188-92
pubmed: 8919848
Anaesthesist. 1998 Nov;47 Suppl 1:S77-86
pubmed: 9893886

Auteurs

Fatemeh Kargar Shouroki (F)

Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.

Masoud Neghab (M)

Department of Occupational Health Engineering, Research Center for Health Sciences, Institute of Health, School of Health, Shiraz University of Medical Sciences, P.O. Box: 71645-111, Shiraz, Iran. neghabm@sums.ac.ir.

Hossein Mozdarani (H)

Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.

Hamzeh Alipour (H)

Research Center for Health Sciences, Institute of health, Shiraz University of Medical Sciences, Shiraz, Iran.

Saeed Yousefinejad (S)

Department of Occupational Health Engineering, School of Health, Shiraz University of Medical Sciences, Shiraz, Iran.

Reza Fardid (R)

Department of Radiology, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH